Audhya Paul K.

CHIEF MEDICAL OFFICER

Audhya Paul K. has filed 9 SEC Form 4 filings (19 transaction rows) across 1 company, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Jun 11, 2026.

On the most recent filing, Audhya Paul K. is listed as CHIEF MEDICAL OFFICER at KalVista Pharmaceuticals, Inc. Inside the rolling window, Audhya Paul K. reported no open-market purchases and 8 open-market sales totaling $430K in KALV. The largest disclosed transaction in the window is a sale of 5,354 KALV shares on Feb 23, 2026, worth $83K.

Companies traded

Other insiders at KALV

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$430K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
KALVSale$60KMay 27SEC ↗
KALVSale$72KMay 26SEC ↗
KALVSale$28KMay 19SEC ↗
KALVSale$54KApr 20SEC ↗
KALVSale$83KFeb 24SEC ↗
KALVSale$17KFeb 19SEC ↗
KALVSale$71KNov 26SEC ↗
KALVSale$45KNov 19SEC ↗

Frequently asked questions

How many SEC Form 4 filings has Audhya Paul K. made?

Audhya Paul K. has filed 9 SEC Form 4 filings (19 transaction rows) across 1 company since 2025.

Which companies does Audhya Paul K. trade?

Audhya Paul K. has filed SEC Form 4 disclosures for 1 company, including KALV.

When was Audhya Paul K.'s most recent SEC Form 4 filing?

Audhya Paul K.'s most recent SEC Form 4 filing on Tracefour is dated Jun 11, 2026.

What is Audhya Paul K.'s job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Audhya Paul K. is listed as CHIEF MEDICAL OFFICER.

What is Audhya Paul K.'s total buy and sell value in the current window?

Inside the rolling retention window, Audhya Paul K. bought $0 and sold $430K based on SEC Form 4 filings.

What was Audhya Paul K.'s largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 5,354 KALV shares on 2026-02-23, worth $83K, per SEC Form 4 filings.